Kumar Ashok, Bean Linda A, Rani Asha, Jackson Travis, Foster Thomas C
Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida.
Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Hippocampus. 2015 Dec;25(12):1556-66. doi: 10.1002/hipo.22475. Epub 2015 Jun 12.
Estradiol rapidly modulates hippocampal synaptic plasticity and synaptic transmission; however, the contribution of the various estrogen receptors to rapid changes in synaptic function is unclear. This study examined the effect of estrogen receptor selective agonists on hippocampal synaptic transmission in slices obtained from 3-5-month-old wild type (WT), estrogen receptor alpha (ERαKO), and beta (ERβKO) knockout female ovariectomized mice. Hippocampal slices were prepared 10-16 days following ovariectomy and extracellular excitatory postsynaptic field potentials were recorded from CA3-CA1 synaptic contacts before and following application of 17β-estradiol-3-benzoate (EB, 100 pM), the G-protein estrogen receptor 1 (GPER1) agonist G1 (100 nM), the ERα selective agonist propyl pyrazole triol (PPT, 100 nM), or the ERβ selective agonist diarylpropionitrile (DPN, 1 µM). Across all groups, EB and G1 increased the synaptic response to a similar extent. Furthermore, prior G1 application occluded the EB-mediated enhancement of the synaptic response and the GPER1 antagonist, G15 (100 nM), inhibited the enhancement of the synaptic response induced by EB application. We confirmed that the ERα and ERβ selective agonists (PPT and DPN) had effects on synaptic responses specific to animals that expressed the relevant receptor; however, PPT and DPN produced only a small increase in synaptic transmission relative to EB or the GPER1 agonist. We demonstrate that the increase in synaptic transmission is blocked by inhibition of extracellular signal-regulated kinase (ERK) activity. Furthermore, EB was able to increase ERK activity regardless of genotype. These results suggest that ERK activation and enhancement of synaptic transmission by EB involves multiple estrogen receptor subtypes.
雌二醇能迅速调节海马体突触可塑性和突触传递;然而,各种雌激素受体对突触功能快速变化的作用尚不清楚。本研究检测了雌激素受体选择性激动剂对从3至5月龄野生型(WT)、雌激素受体α(ERαKO)和β(ERβKO)基因敲除的去卵巢雌性小鼠获取的脑片中海马体突触传递的影响。在去卵巢后10至16天制备海马体脑片,并在施加17β-雌二醇-3-苯甲酸酯(EB,100 pM)、G蛋白雌激素受体1(GPER1)激动剂G1(100 nM)、ERα选择性激动剂丙基吡唑三醇(PPT,100 nM)或ERβ选择性激动剂二芳基丙腈(DPN,1 µM)之前和之后,记录CA3-CA1突触连接处的细胞外兴奋性突触后场电位。在所有组中,EB和G1对突触反应的增强程度相似。此外,预先施加G1会阻断EB介导的突触反应增强,并且GPER1拮抗剂G15(100 nM)会抑制EB施加诱导的突触反应增强。我们证实,ERα和ERβ选择性激动剂(PPT和DPN)对表达相关受体的动物的突触反应有特异性影响;然而,相对于EB或GPER1激动剂,PPT和DPN仅使突触传递有小幅增加。我们证明,细胞外信号调节激酶(ERK)活性的抑制会阻断突触传递的增加。此外,无论基因型如何,EB都能够增加ERK活性。这些结果表明,EB激活ERK并增强突触传递涉及多种雌激素受体亚型。